1. Norris, JM, Johnson, RK, Stene, LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. 2020;8:226-238. doi:10.1016/S2213-8587(19)30412-7
Google Scholar | Crossref | Medline2. Cho, NH, Shaw, JE, Karuranga, S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281. doi:10.1016/j.diabres.2018.02.023
Google Scholar | Crossref | Medline3. Atkinson, MA, Eisenbarth, GS, Michels, AW. Type 1 diabetes. Lancet. 2014;383:69-82. doi:10.1016/S0140-6736(13)60591-7
Google Scholar | Crossref | Medline | ISI4. Monnier, L, Mas, E, Ginet, C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687. doi:10.1001/jama.295.14.1681
Google Scholar | Crossref | Medline | ISI5. Kilpatrick, ES, Rigby, AS, Atkin, SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006;29:1486-1490. doi:10.2337/dc06-0293
Google Scholar | Crossref | Medline | ISI6. Lachin, JM, Bebu, I, Bergenstal, RM, et al. Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complications trial. Diabetes Care. 2017;40:777-783. doi:10.2337/dc16-2426
Google Scholar | Crossref | Medline | ISI7. Suh, S, Kim, JH. Glycemic variability: how do we measure it and why is it important? Diabetes Metab J. 2015;39:273-282. doi:10.4093/dmj.2015.39.4.273
Google Scholar | Crossref | Medline8. Kilpatrick, ES, Rigby, AS, Goode, K, Atkin, SL. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia. 2007;50:2553-2561. doi:10.1007/s00125-007-0820-z
Google Scholar | Crossref | Medline | ISI9. Hirsch, IB, Amiel, SA, Blumer, IR, et al. Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers. Diabetes Technol Ther. 2012;14:973-983; quiz 83. doi:10.1089/dia.2012.0132
Google Scholar | Crossref | Medline | ISI10. Battelino, T, Danne, T, Bergenstal, RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593-1603. doi:10.2337/dci19-0028
Google Scholar | Crossref | Medline11. Siegelaar, SE, Holleman, F, Hoekstra, JB, DeVries, JH. Glucose variability: does it matter? Endocr Rev. 2010;31:171-182. doi:10.1210/er.2009-0021
Google Scholar | Crossref | Medline | ISI12. Danne, T, Nimri, R, Battelino, T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631-1640. doi:10.2337/dc17-1600
Google Scholar | Crossref | Medline13. Diabetes Canada Clinical Practice Guidelines Expert Committee ,Berard, LD, Siemens, R, Woo, V. Monitoring glycemic control. Can J Diabetes. 2018;42:S47-S53. doi:10.1016/j.jcjd.2017.10.007
Google Scholar | Crossref | Medline14. Robert, AA, Al-Dawish, A, Mujammami, M, Dawish, MAA. Type 1 diabetes mellitus in Saudi Arabia: a soaring epidemic. Int J Pediatr. 2018;2018:9408370. doi:10.1155/2018/9408370
Google Scholar | Crossref | Medline15. Al-Agha, AE, Alafif, MM, Abd-Elhameed, IA. Glycemic control, complications, and associated autoimmune diseases in children and adolescents with type 1 diabetes in Jeddah, Saudi Arabia. Saudi Med J. 2015;36:26-31. doi:10.15537/smj.2015.1.9829
Google Scholar | Crossref | Medline16. Ahmed, AM, Al-Maghamsi, M, Al-Harbi, AM, Eid, IM, Baghdadi, HH, Habeb, AM. Reduced frequency and severity of ketoacidosis at diagnosis of childhood type 1 diabetes in Northwest Saudi Arabia. J Pediatr Endocrinol Metab. 2016;29:259-264. doi:10.1515/jpem-2015-0077
Google Scholar | Crossref | Medline17. F John Service . Glucose variability. Diabetes. 2013;62:1398-1404. doi:10.2337/db12-1396
Google Scholar | Crossref | Medline18. Bergenstal, RM. Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers! Diabetes Care. 2015;38:1615-1621. doi:10.2337/dc15-0099
Google Scholar | Crossref | Medline | ISI19. Cryer, PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia. 2002;45:937-948. doi:10.1007/s00125-002-0822-9
Google Scholar | Crossref | Medline | ISI20. Gomez-Peralta, F, Dunn, T, Landuyt, K, Xu, Y, Merino-Torres, JF. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ Open Diabetes Res Care. 2020;8:e001052. doi:10.1136/bmjdrc-2019-001052
Google Scholar | Crossref21. Beck, RW, Bergenstal, RM, Cheng, P, et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol. 2019;13:614-626. doi:10.1177/1932296818822496
Google Scholar | SAGE Journals22. Brazeau, AS, Mircescu, H, Desjardins, K, et al. Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes. Diabetes Res Clin Pract. 2013;99:19-23. doi:10.1016/j.diabres.2012.10.024
Google Scholar | Crossref | Medline | ISI23. Deeb, A, Yousef, H, Al Qahtani, N, et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord. 2019;18:1-6. doi:10.1007/s40200-018-0351-9
Google Scholar | Crossref | Medline24. Nakamura, T, Sakaguchi, K, So, A, et al. Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study. Diabetologia. 2015;58:2013-2019. doi:10.1007/s00125-015-3648-y
Google Scholar | Crossref | Medline25. Kuenen, JC, Borg, R, Kuik, DJ, et al. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients? Diabetes Care. 2011;34:1843-1847. doi:10.2337/dc10-2217
Google Scholar | Crossref | Medline | ISI26. Jangam, S, Dunn, T, Xu, Y, Hayter, G, Ajjan, RA. Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings. BMJ Open Diabetes Res Care. 2019;7:e000611. doi:10.1136/bmjdrc-2018-000611
Google Scholar | Crossref | Medline27. Freckmann, G, Link, M, Pleus, S, Westhoff, A, Kamecke, U, Haug, C. Measurement performance of two continuous tissue glucose monitoring systems intended for replacement of blood glucose monitoring. Diabetes Technol Ther. 2018;20:541-549. doi:10.1089/dia.2018.0105
Google Scholar | Crossref | Medline